Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study

In this prospective observational study, data were collected from 34 rheumatology clinics in Italy in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) who started golimumab (GLM) as a second anti-TNFα drug. The primary objective was to evaluate t...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Angelo, Salvatore, Tirri, Enrico, Giardino, Angela Maria, Mattucci-Cerinic, Marco, Dagna, Lorenzo, Santo, Leonardo, Ciccia, Francesco, Frediani, Bruno, Govoni, Marcello, Bobbio Pallavicini, Francesca, Grembiale, Rosa Daniela, Delle Sedie, Andrea, Mulè, Rita, Cantatore, Francesco Paolo, Foti, Rosario, Gremese, Elisa, Conigliaro, Paola, Salaffi, Fausto, Viapiana, Ombretta, Cauli, Alberto, Giacomelli, Roberto, Arcarese, Luisa, Guggino, Giuliana, Russo, Romualdo, Puenpatom, Amy, Capocotta, Domenico, Nacci, Francesca, Anelli, Maria Grazia, Picerno, Valentina, Binetti, Corrado, Iannone, Florenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322086/
https://www.ncbi.nlm.nih.gov/pubmed/35887946
http://dx.doi.org/10.3390/jcm11144178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322086/
https://www.ncbi.nlm.nih.gov/pubmed/35887946
http://dx.doi.org/10.3390/jcm11144178

Ejemplares similares